DEA Reviews Application from Catalent Greenville
January 31, 2025
January 31, 2025
WASHINGTON, Jan. 31 (TNSFR) -- The Drug Enforcement Administration has announced that Catalent Greenville, Inc. has applied for registration as an importer of a Schedule I controlled substance. The company, based in Greenville, North Carolina, seeks authorization to import 3,4-Methylenedioxymethamphetamine (MDMA) for research, clinical trial studies, and analytical purposes.
According to the application, no other activities related to this substance will be permitted under the requ . . .
According to the application, no other activities related to this substance will be permitted under the requ . . .